NICE draft guideline on PMOS recommends a yearly check and quicker diagnosis
NICE has published a draft guideline on polyendocrine metabolic ovarian syndrome (PMOS), formerly called PCOS, for public consultation.
Key points
- The draft guideline was open for feedback from 1 July to 11 August 2026.
- NICE says people with PMOS should be offered a yearly check covering symptoms, treatment and long-term health risks.
- NICE says the draft aims for diagnosis to happen sooner.
What was announced
NICE has published a draft guideline on polyendocrine metabolic ovarian syndrome (PMOS), the condition formerly called polycystic ovary syndrome (PCOS), for public consultation. The draft was open for feedback from healthcare professionals, patients and the public from 1 July to 11 August 2026. It adapts the 2023 international guideline on PCOS to UK practice.
What it means
NICE says people with PMOS should be offered a yearly check covering symptoms, treatment and long-term health risks, and that diagnosis should happen sooner. The draft sets out detailed guidance on when to suspect the condition, and says PMOS should not be ruled out after menopause.
More guides and news
- MHRA approves icotrokinra for psoriasis Health news · 23 October 2026
- MHRA publishes pneumococcal vaccine factsheet Health news · 27 October 2026
- Heavy periods: causes, tests and treatment Guide · 3 November 2026
- Periods: what is normal and when to see a GP Guide · 3 November 2026